Mana.bio Unveils AI-Designed Lipid Nanoparticles with Andreessen Horowitz Backing

Israeli startup Mana.bio has raised $19.5 million in seed financing from investors including Andreessen Horowitz Bio + Health, Base4 Capital, NFX, LionBird, and Technion - Israel Institute of Technology. The company aims to address the challenge of delivering genetic medicines to specific cells or organs by developing AI-designed lipid nanoparticles, which can be used to transport mRNA molecules for vaccines or gene therapies.